Positive allosteric modulation of alpha7 nicotinic acetylcholine receptors as a novel approach to treatment of ischemic stroke

Simple item page
dc.contributor.advisorUteshev, Victor V.
dc.contributor.committeeMemberJin, Kunlin
dc.contributor.committeeMemberYang, Shaohua
dc.contributor.committeeMemberBerg, Rance E.
dc.contributor.committeeMemberRosales, Armando
dc.creatorGaidhani, Nikhil, M.
dc.date.accessioned2019-12-03T15:18:14Z
dc.date.available2019-12-03T15:18:14Z
dc.date.issued2017-12
dc.description.abstractIschemic cerebral stroke is a leading cause of disability and death worldwide. Despite substantial investments in developing anti-stroke medicines, clinically effective pharmacological treatments remain inadequate. Clinical utility of tissue plasminogen activator (tPA, Alteplase), the only FDA-approved drug treatment is limited ([less than]10%) because of the short therapeutic window and increased risk of hemorrhage. Cytoprotection is a promising stroke therapy compatible with endovascular interventions, neurogenesis and rehabilitation therapies (e.g., targeted plasticity). In this fully randomized blinded study, an effective cytoprotection strategy for ischemic stroke is proposed. In this approach, prototypical and novel Type II positive allosteric modulators (ɑ7 PAMs) of ɑ7 nicotinic acetylcholine receptors (nAChRs) were tested using a transient 90 min suture middle cerebral artery occlusion (MCAO) model of ischemic stroke. Acute ([less than]24 h) and sub-chronic ([greater than]72 h) intravenous (i.v.) or subcutaneous (s.c.) administration of ɑ7 PAMs significantly reduced brain injury and neurological deficits after MCAO. The therapeutic efficacy of ɑ7 PAMs after stroke may arise from activation of multiple converging ɑ7-dependent therapeutic pathways including direct cytoprotection and central/peripheral anti-inflammatory mechanisms and may hold significant translational potential. Our results may become a starting point for developing clinically efficacious therapies utilizing ɑ7 agents and may enable health-care providers to overcome limitations linked to the lack of effective treatments after stroke.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12503/29760
dc.language.isoen
dc.subjectischemic brain stroke
dc.subjectmiddle cerebral artery occlusion
dc.subjectPNU 120596
dc.subjectpositive allosteric modulators
dc.subjectstroke treatment
dc.subjectvagus nerve stimulation
dc.subject.meshStroke/drug therapy
dc.subject.meshAllosteric Regulation
dc.subject.meshBrain Ischemia/drug therapy
dc.subject.meshCytoprotection
dc.subject.meshTissue Plasminogen Activator/metabolism
dc.titlePositive allosteric modulation of alpha7 nicotinic acetylcholine receptors as a novel approach to treatment of ischemic stroke
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentGraduate School of Biomedical Sciences
thesis.degree.disciplinePharmacology and Neuroscience
thesis.degree.grantorUniversity of North Texas Health Science Center at Fort Worth
thesis.degree.nameDoctor of Philosophy

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2017_12_gsbs_Gaidhani_Nikhil_dissertation.pdf
Size:
1.96 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

School of Biomedical Sciences
Theses and Dissertations